Skip Navigation

Health: Drug development

pharmaCoMalariavaccine_shanghai_whotdrcrump

A rising generics industry in developing nations is helping secure access to cheap drugs for the world's poor. But controversies over patent rules could divert investment from already neglected diseases.

(Photo credit: WHO/TDR/Crump)

Opinions and Analysis

Priority review vouchers might not be the way forward

FDA priority review vouchers will not necessarily encourage research into tropical diseases, argues Aaron Kesselheim.

18 November 2008 | EN | 中文
Source: New England Journal of Medicine

Progress in Chinese biomedicine a massive challenge

Developing biomedical research in China poses a massive challenge, says Zhu Chen.

23 October 2008 | EN | 中文
Source: The Lancet

Back to basics for malaria research

13 October 2008 | EN
Source: Nature

Drug-resistant TB needs massive research increase

17 July 2008 | EN | 中文
Source: PLoS Medicine

MORE Opinions MORE Analysis

News and Features

Malaria vaccine on the way to final-stage trials

A malaria vaccine looks set to enter final-stage clinical trials after earlier trials deemed it effective and safe to use alongside other vaccines.

16 December 2008 | EN | 中文

Drugs may be the next frontier for HIV prevention

Following the failure of vaccine and microbicide trials, scientists say they will study antiretroviral drugs for HIV prevention.

12 December 2008 | EN | ES | 中文

Laws to protect native knowledge 'are failing'

28 November 2008 | EN | ES | 中文

New malaria drug technologies unveiled

24 November 2008 | EN | 中文

MORE News MORE Features

Information Services

Where is science in the developing world?

A series of articles, written by TWAS members and published by Nature, discusses the status of science in the South

Raising the alarm for chronic diseases

Why chronic diseases in the developing world need to become a bigger global health priority